1. Home
  2. KTF vs VCEL Comparison

KTF vs VCEL Comparison

Compare KTF & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DWS Municipal Income Trust

KTF

DWS Municipal Income Trust

HOLD

Current Price

$9.13

Market Cap

365.1M

Sector

Finance

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$37.53

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KTF
VCEL
Founded
1988
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
365.1M
2.0B
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
KTF
VCEL
Price
$9.13
$37.53
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$57.50
AVG Volume (30 Days)
103.3K
586.8K
Earning Date
01-01-0001
02-26-2026
Dividend Yield
3.54%
N/A
EPS Growth
N/A
236.54
EPS
0.39
0.25
Revenue
N/A
$258,716,999.00
Revenue This Year
N/A
$17.86
Revenue Next Year
N/A
$18.55
P/E Ratio
$23.10
$151.65
Revenue Growth
N/A
14.05
52 Week Low
$7.40
$29.24
52 Week High
$9.12
$63.00

Technical Indicators

Market Signals
Indicator
KTF
VCEL
Relative Strength Index (RSI) 51.82 48.73
Support Level $9.09 $35.99
Resistance Level $9.15 $41.65
Average True Range (ATR) 0.04 1.75
MACD 0.01 -0.01
Stochastic Oscillator 75.00 32.12

Price Performance

Historical Comparison
KTF
VCEL

About KTF DWS Municipal Income Trust

DWS Municipal Income Trust is a closed-ended fixed income mutual fund launched and managed by Deutsche Investment Management Americas, Inc. The company invests in the fixed income markets of the United States. The fund invests in investment-grade tax-exempt municipal securities which are exempt from federal income tax. The fund benchmarks the performance of its portfolio against the Barclays Municipal Bond Index. The Fund invests in various states, such as Texas, Florida, Pennsylvania, Illinois, and California.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: